NPCE vs TOST · rev $22.8M vs P/E 161, rev $3.54B
Neuropace Inc (NPCE) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported NPCE revenue for 2026-06-30 was $22.8M. Net income was -$6.2M. Revenue was up 3.4% from 2026-03-31 to 2026-06-30. NPCE currently screens at market cap $312.2M.
Latest reported TOST revenue for 2026-06-30 was $3.54B. Net income was $280.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
NPCE currently screens at market cap $312.2M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the NPCE and TOST stock pages for the full models.
Not investment advice.